Best practice recommendations for bioinformatics approaches applied to high-throughput sequencing for rare disease and cancer diagnosis within the UK National Health Service.
Updated UK standards for genomic testing in rare disease and cancer aim to ensure consistent, high-quality diagnosis across the NHS.
A consortium of NHS bioinformaticians developed updated national best practice recommendations for bioinformatics approaches applied to high-throughput genomic sequencing in clinical diagnostics for rare disease and cancer. The framework encompasses quality control through variant classification and applies to targeted and whole genome sequencing of germline and tumor samples, aiming to promote consistency and innovation across UK NHS genomic testing services.
What the study was
- Study design
- Consensus guideline / best practice recommendations
- Population
- UK NHS patients undergoing clinical genomic testing for rare disease and cancer
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Journal of Medical Genetics
Why it surfaced
National guideline paper from NHS with direct implementation value for rare disease and cancer genomics workflows; broad relevance to clinical genomic medicine practice. NEAR_TERM_IMPLEMENTABLE flag reflects direct policy/practice applicability.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.